nodes	percent_of_prediction	percent_of_DWPC	metapath
Bismuth Subsalicylate—TF—lung cancer	0.492	0.797	CbGaD
Bismuth Subsalicylate—PTGS2—lung cancer	0.0661	0.107	CbGaD
Bismuth Subsalicylate—ALB—lung cancer	0.0589	0.0955	CbGaD
Bismuth Subsalicylate—ALB—Gefitinib—lung cancer	0.0484	0.23	CbGbCtD
Bismuth Subsalicylate—PTGS2—Cisplatin—lung cancer	0.0334	0.159	CbGbCtD
Bismuth Subsalicylate—PTGS2—Etoposide—lung cancer	0.0328	0.156	CbGbCtD
Bismuth Subsalicylate—ALB—Erlotinib—lung cancer	0.0286	0.136	CbGbCtD
Bismuth Subsalicylate—PTGS1—Etoposide—lung cancer	0.0277	0.132	CbGbCtD
Bismuth Subsalicylate—ALB—Irinotecan—lung cancer	0.0258	0.123	CbGbCtD
Bismuth Subsalicylate—ALB—Methotrexate—lung cancer	0.0137	0.065	CbGbCtD
Bismuth Subsalicylate—TF—respiratory system—lung cancer	0.00146	0.129	CbGeAlD
Bismuth Subsalicylate—TF—epithelium—lung cancer	0.00122	0.108	CbGeAlD
Bismuth Subsalicylate—TF—bronchus—lung cancer	0.0012	0.107	CbGeAlD
Bismuth Subsalicylate—ALB—mammary gland—lung cancer	0.00114	0.101	CbGeAlD
Bismuth Subsalicylate—TF—bone marrow—lung cancer	0.000857	0.0759	CbGeAlD
Bismuth Subsalicylate—TF—lung—lung cancer	0.000777	0.0687	CbGeAlD
Bismuth Subsalicylate—TF—lymph node—lung cancer	0.000531	0.047	CbGeAlD
Bismuth Subsalicylate—PTGS1—respiratory system—lung cancer	0.000434	0.0384	CbGeAlD
Bismuth Subsalicylate—PTGS2—respiratory system—lung cancer	0.000414	0.0367	CbGeAlD
Bismuth Subsalicylate—PTGS1—epithelium—lung cancer	0.000362	0.0321	CbGeAlD
Bismuth Subsalicylate—PTGS2—epithelium—lung cancer	0.000346	0.0307	CbGeAlD
Bismuth Subsalicylate—PTGS2—bronchus—lung cancer	0.000341	0.0302	CbGeAlD
Bismuth Subsalicylate—PTGS1—trachea—lung cancer	0.00032	0.0284	CbGeAlD
Bismuth Subsalicylate—PTGS2—trachea—lung cancer	0.000306	0.0271	CbGeAlD
Bismuth Subsalicylate—PTGS1—cardiac atrium—lung cancer	0.000301	0.0266	CbGeAlD
Bismuth Subsalicylate—ALB—lymph node—lung cancer	0.000276	0.0245	CbGeAlD
Bismuth Subsalicylate—PTGS2—bone marrow—lung cancer	0.000243	0.0215	CbGeAlD
Bismuth Subsalicylate—PTGS1—lung—lung cancer	0.00023	0.0204	CbGeAlD
Bismuth Subsalicylate—PTGS2—lung—lung cancer	0.00022	0.0195	CbGeAlD
Bismuth Subsalicylate—Pruritus—Teniposide—lung cancer	0.000219	0.00235	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Topotecan—lung cancer	0.000218	0.00234	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Erlotinib—lung cancer	0.000216	0.00232	CcSEcCtD
Bismuth Subsalicylate—Skin exfoliation—Methotrexate—lung cancer	0.000215	0.00231	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Teniposide—lung cancer	0.000211	0.00227	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Paclitaxel—lung cancer	0.000211	0.00226	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Gemcitabine—lung cancer	0.00021	0.00225	CcSEcCtD
Bismuth Subsalicylate—Abdominal pain upper—Docetaxel—lung cancer	0.000208	0.00223	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Vinblastine—lung cancer	0.000205	0.0022	CcSEcCtD
Bismuth Subsalicylate—Ecchymosis—Methotrexate—lung cancer	0.000204	0.00219	CcSEcCtD
Bismuth Subsalicylate—Pain—Vinblastine—lung cancer	0.000202	0.00216	CcSEcCtD
Bismuth Subsalicylate—Constipation—Vinblastine—lung cancer	0.000202	0.00216	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Topotecan—lung cancer	0.000202	0.00216	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Erlotinib—lung cancer	0.000199	0.00214	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Topotecan—lung cancer	0.000199	0.00214	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Erlotinib—lung cancer	0.000197	0.00211	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Teniposide—lung cancer	0.000196	0.00211	CcSEcCtD
Bismuth Subsalicylate—Constipation—Topotecan—lung cancer	0.000196	0.0021	CcSEcCtD
Bismuth Subsalicylate—Pain—Topotecan—lung cancer	0.000196	0.0021	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Paclitaxel—lung cancer	0.000195	0.00209	CcSEcCtD
Bismuth Subsalicylate—Rash—Teniposide—lung cancer	0.000195	0.00209	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Teniposide—lung cancer	0.000195	0.00209	CcSEcCtD
Bismuth Subsalicylate—Infection—Vinorelbine—lung cancer	0.000195	0.00209	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Vinblastine—lung cancer	0.000194	0.00208	CcSEcCtD
Bismuth Subsalicylate—Pain—Erlotinib—lung cancer	0.000194	0.00208	CcSEcCtD
Bismuth Subsalicylate—Constipation—Erlotinib—lung cancer	0.000194	0.00208	CcSEcCtD
Bismuth Subsalicylate—Headache—Teniposide—lung cancer	0.000194	0.00208	CcSEcCtD
Bismuth Subsalicylate—Erythema—Gemcitabine—lung cancer	0.000193	0.00207	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Cisplatin—lung cancer	0.000193	0.00207	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Topotecan—lung cancer	0.000189	0.00202	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Vinorelbine—lung cancer	0.000187	0.002	CcSEcCtD
Bismuth Subsalicylate—Skin exfoliation—Doxorubicin—lung cancer	0.000187	0.002	CcSEcCtD
Bismuth Subsalicylate—Nausea—Teniposide—lung cancer	0.000184	0.00197	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Topotecan—lung cancer	0.000182	0.00195	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Topotecan—lung cancer	0.000181	0.00194	CcSEcCtD
Bismuth Subsalicylate—Erythema—Cisplatin—lung cancer	0.00018	0.00193	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Erlotinib—lung cancer	0.000179	0.00192	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Etoposide—lung cancer	0.000179	0.00192	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Docetaxel—lung cancer	0.000179	0.00192	CcSEcCtD
Bismuth Subsalicylate—Oesophagitis—Doxorubicin—lung cancer	0.000179	0.00192	CcSEcCtD
Bismuth Subsalicylate—Ecchymosis—Doxorubicin—lung cancer	0.000177	0.0019	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Paclitaxel—lung cancer	0.000175	0.00188	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Paclitaxel—lung cancer	0.000173	0.00186	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Vinorelbine—lung cancer	0.00017	0.00183	CcSEcCtD
Bismuth Subsalicylate—Constipation—Vinorelbine—lung cancer	0.000168	0.0018	CcSEcCtD
Bismuth Subsalicylate—Pain—Vinorelbine—lung cancer	0.000168	0.0018	CcSEcCtD
Bismuth Subsalicylate—Lethargy—Methotrexate—lung cancer	0.000167	0.00179	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Docetaxel—lung cancer	0.000165	0.00177	CcSEcCtD
Bismuth Subsalicylate—Phlebitis—Doxorubicin—lung cancer	0.000165	0.00177	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Irinotecan—lung cancer	0.000163	0.00175	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Topotecan—lung cancer	0.000162	0.00174	CcSEcCtD
Bismuth Subsalicylate—Oedema—Irinotecan—lung cancer	0.000162	0.00173	CcSEcCtD
Bismuth Subsalicylate—Erythema—Paclitaxel—lung cancer	0.000161	0.00173	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Vinorelbine—lung cancer	0.000161	0.00173	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Vinblastine—lung cancer	0.000161	0.00173	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Etoposide—lung cancer	0.000161	0.00173	CcSEcCtD
Bismuth Subsalicylate—Infection—Irinotecan—lung cancer	0.000161	0.00172	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Erlotinib—lung cancer	0.00016	0.00172	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Paclitaxel—lung cancer	0.000158	0.0017	CcSEcCtD
Bismuth Subsalicylate—PTGS1—lymph node—lung cancer	0.000157	0.0139	CbGeAlD
Bismuth Subsalicylate—Oedema—Gemcitabine—lung cancer	0.000157	0.00169	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Docetaxel—lung cancer	0.000157	0.00169	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Topotecan—lung cancer	0.000157	0.00168	CcSEcCtD
Bismuth Subsalicylate—Infection—Gemcitabine—lung cancer	0.000156	0.00168	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Vinblastine—lung cancer	0.000156	0.00167	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Vinorelbine—lung cancer	0.000156	0.00167	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Erlotinib—lung cancer	0.000155	0.00166	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Vinorelbine—lung cancer	0.000155	0.00166	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Irinotecan—lung cancer	0.000154	0.00165	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Topotecan—lung cancer	0.000151	0.00162	CcSEcCtD
Bismuth Subsalicylate—PTGS2—lymph node—lung cancer	0.000151	0.0133	CbGeAlD
Bismuth Subsalicylate—Anorexia—Gemcitabine—lung cancer	0.00015	0.00161	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Vinblastine—lung cancer	0.00015	0.00161	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Erlotinib—lung cancer	0.00015	0.00161	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Docetaxel—lung cancer	0.000149	0.00159	CcSEcCtD
Bismuth Subsalicylate—Headache—Vinblastine—lung cancer	0.000148	0.00158	CcSEcCtD
Bismuth Subsalicylate—Oedema—Cisplatin—lung cancer	0.000147	0.00157	CcSEcCtD
Bismuth Subsalicylate—Infection—Cisplatin—lung cancer	0.000146	0.00156	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Topotecan—lung cancer	0.000146	0.00156	CcSEcCtD
Bismuth Subsalicylate—Lethargy—Doxorubicin—lung cancer	0.000145	0.00155	CcSEcCtD
Bismuth Subsalicylate—Rash—Topotecan—lung cancer	0.000144	0.00155	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Topotecan—lung cancer	0.000144	0.00155	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Erlotinib—lung cancer	0.000144	0.00155	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Irinotecan—lung cancer	0.000144	0.00154	CcSEcCtD
Bismuth Subsalicylate—Headache—Topotecan—lung cancer	0.000144	0.00154	CcSEcCtD
Bismuth Subsalicylate—Rash—Erlotinib—lung cancer	0.000143	0.00153	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Erlotinib—lung cancer	0.000143	0.00153	CcSEcCtD
Bismuth Subsalicylate—Hyponatraemia—Doxorubicin—lung cancer	0.000142	0.00153	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Irinotecan—lung cancer	0.000142	0.00153	CcSEcCtD
Bismuth Subsalicylate—Headache—Erlotinib—lung cancer	0.000142	0.00152	CcSEcCtD
Bismuth Subsalicylate—Asthma—Methotrexate—lung cancer	0.000142	0.00152	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Irinotecan—lung cancer	0.00014	0.00151	CcSEcCtD
Bismuth Subsalicylate—Nausea—Vinblastine—lung cancer	0.00014	0.0015	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Gemcitabine—lung cancer	0.00014	0.0015	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Cisplatin—lung cancer	0.00014	0.0015	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Vinorelbine—lung cancer	0.000139	0.00149	CcSEcCtD
Bismuth Subsalicylate—Constipation—Irinotecan—lung cancer	0.000138	0.00148	CcSEcCtD
Bismuth Subsalicylate—Pain—Irinotecan—lung cancer	0.000138	0.00148	CcSEcCtD
Bismuth Subsalicylate—Erythema—Docetaxel—lung cancer	0.000137	0.00147	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Gemcitabine—lung cancer	0.000137	0.00147	CcSEcCtD
Bismuth Subsalicylate—Nausea—Topotecan—lung cancer	0.000136	0.00146	CcSEcCtD
Bismuth Subsalicylate—Abdominal discomfort—Methotrexate—lung cancer	0.000136	0.00146	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Etoposide—lung cancer	0.000136	0.00145	CcSEcCtD
Bismuth Subsalicylate—Pain—Gemcitabine—lung cancer	0.000135	0.00144	CcSEcCtD
Bismuth Subsalicylate—Constipation—Gemcitabine—lung cancer	0.000135	0.00144	CcSEcCtD
Bismuth Subsalicylate—Nausea—Erlotinib—lung cancer	0.000135	0.00144	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Vinorelbine—lung cancer	0.000134	0.00144	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Docetaxel—lung cancer	0.000134	0.00144	CcSEcCtD
Bismuth Subsalicylate—Infection—Etoposide—lung cancer	0.000134	0.00143	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Irinotecan—lung cancer	0.000133	0.00143	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Paclitaxel—lung cancer	0.000133	0.00143	CcSEcCtD
Bismuth Subsalicylate—Oedema—Paclitaxel—lung cancer	0.000132	0.00141	CcSEcCtD
Bismuth Subsalicylate—Infection—Paclitaxel—lung cancer	0.000131	0.0014	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Gemcitabine—lung cancer	0.00013	0.00139	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Vinorelbine—lung cancer	0.00013	0.00139	CcSEcCtD
Bismuth Subsalicylate—Abdominal pain upper—Doxorubicin—lung cancer	0.00013	0.00139	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Etoposide—lung cancer	0.000128	0.00137	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Irinotecan—lung cancer	0.000128	0.00137	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Cisplatin—lung cancer	0.000128	0.00137	CcSEcCtD
Bismuth Subsalicylate—Drowsiness—Methotrexate—lung cancer	0.000126	0.00135	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Paclitaxel—lung cancer	0.000126	0.00135	CcSEcCtD
Bismuth Subsalicylate—Pain—Cisplatin—lung cancer	0.000125	0.00135	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Vinorelbine—lung cancer	0.000125	0.00134	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Gemcitabine—lung cancer	0.000124	0.00133	CcSEcCtD
Bismuth Subsalicylate—Rash—Vinorelbine—lung cancer	0.000124	0.00133	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Vinorelbine—lung cancer	0.000123	0.00132	CcSEcCtD
Bismuth Subsalicylate—Headache—Vinorelbine—lung cancer	0.000123	0.00132	CcSEcCtD
Bismuth Subsalicylate—Asthma—Doxorubicin—lung cancer	0.000123	0.00132	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Cisplatin—lung cancer	0.000121	0.0013	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Etoposide—lung cancer	0.00012	0.00128	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Methotrexate—lung cancer	0.000119	0.00128	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Paclitaxel—lung cancer	0.000117	0.00126	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Etoposide—lung cancer	0.000117	0.00125	CcSEcCtD
Bismuth Subsalicylate—Nausea—Vinorelbine—lung cancer	0.000116	0.00125	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Paclitaxel—lung cancer	0.000116	0.00124	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Cisplatin—lung cancer	0.000116	0.00124	CcSEcCtD
Bismuth Subsalicylate—Pain—Etoposide—lung cancer	0.000115	0.00123	CcSEcCtD
Bismuth Subsalicylate—Constipation—Etoposide—lung cancer	0.000115	0.00123	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Paclitaxel—lung cancer	0.000115	0.00123	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Methotrexate—lung cancer	0.000113	0.00122	CcSEcCtD
Bismuth Subsalicylate—Pain—Paclitaxel—lung cancer	0.000113	0.00121	CcSEcCtD
Bismuth Subsalicylate—Constipation—Paclitaxel—lung cancer	0.000113	0.00121	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Docetaxel—lung cancer	0.000113	0.00121	CcSEcCtD
Bismuth Subsalicylate—Oedema—Docetaxel—lung cancer	0.000112	0.0012	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Doxorubicin—lung cancer	0.000112	0.0012	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Gemcitabine—lung cancer	0.000111	0.00119	CcSEcCtD
Bismuth Subsalicylate—Infection—Docetaxel—lung cancer	0.000111	0.00119	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Etoposide—lung cancer	0.000111	0.00119	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Irinotecan—lung cancer	0.000111	0.00119	CcSEcCtD
Bismuth Subsalicylate—Drowsiness—Doxorubicin—lung cancer	0.000109	0.00117	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Paclitaxel—lung cancer	0.000109	0.00116	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Gemcitabine—lung cancer	0.000108	0.00116	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Methotrexate—lung cancer	0.000107	0.00115	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Irinotecan—lung cancer	0.000107	0.00115	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Etoposide—lung cancer	0.000107	0.00115	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Docetaxel—lung cancer	0.000106	0.00114	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Etoposide—lung cancer	0.000106	0.00114	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Methotrexate—lung cancer	0.000106	0.00113	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Paclitaxel—lung cancer	0.000105	0.00112	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Paclitaxel—lung cancer	0.000104	0.00112	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Doxorubicin—lung cancer	0.000103	0.00111	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Irinotecan—lung cancer	0.000103	0.0011	CcSEcCtD
Bismuth Subsalicylate—Rash—Irinotecan—lung cancer	0.000102	0.00109	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Irinotecan—lung cancer	0.000102	0.00109	CcSEcCtD
Bismuth Subsalicylate—Headache—Irinotecan—lung cancer	0.000101	0.00109	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Cisplatin—lung cancer	0.0001	0.00108	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Gemcitabine—lung cancer	0.0001	0.00107	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Docetaxel—lung cancer	9.93e-05	0.00107	CcSEcCtD
Bismuth Subsalicylate—Rash—Gemcitabine—lung cancer	9.93e-05	0.00106	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Gemcitabine—lung cancer	9.92e-05	0.00106	CcSEcCtD
Bismuth Subsalicylate—Erythema—Methotrexate—lung cancer	9.87e-05	0.00106	CcSEcCtD
Bismuth Subsalicylate—Headache—Gemcitabine—lung cancer	9.86e-05	0.00106	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Docetaxel—lung cancer	9.83e-05	0.00105	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Doxorubicin—lung cancer	9.81e-05	0.00105	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Docetaxel—lung cancer	9.71e-05	0.00104	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Methotrexate—lung cancer	9.66e-05	0.00104	CcSEcCtD
Bismuth Subsalicylate—Nausea—Irinotecan—lung cancer	9.6e-05	0.00103	CcSEcCtD
Bismuth Subsalicylate—Pain—Docetaxel—lung cancer	9.55e-05	0.00102	CcSEcCtD
Bismuth Subsalicylate—Constipation—Docetaxel—lung cancer	9.55e-05	0.00102	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Etoposide—lung cancer	9.51e-05	0.00102	CcSEcCtD
Bismuth Subsalicylate—Nausea—Gemcitabine—lung cancer	9.35e-05	0.001	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Cisplatin—lung cancer	9.33e-05	0.001	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Paclitaxel—lung cancer	9.32e-05	0.001	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Doxorubicin—lung cancer	9.28e-05	0.000995	CcSEcCtD
Bismuth Subsalicylate—Rash—Cisplatin—lung cancer	9.25e-05	0.000992	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Cisplatin—lung cancer	9.24e-05	0.000991	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Docetaxel—lung cancer	9.21e-05	0.000987	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Etoposide—lung cancer	9.2e-05	0.000987	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Doxorubicin—lung cancer	9.15e-05	0.000981	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Paclitaxel—lung cancer	9.02e-05	0.000967	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Etoposide—lung cancer	8.89e-05	0.000953	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Docetaxel—lung cancer	8.83e-05	0.000947	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Paclitaxel—lung cancer	8.72e-05	0.000935	CcSEcCtD
Bismuth Subsalicylate—Nausea—Cisplatin—lung cancer	8.72e-05	0.000935	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Etoposide—lung cancer	8.55e-05	0.000917	CcSEcCtD
Bismuth Subsalicylate—Erythema—Doxorubicin—lung cancer	8.54e-05	0.000916	CcSEcCtD
Bismuth Subsalicylate—Rash—Etoposide—lung cancer	8.48e-05	0.000909	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Etoposide—lung cancer	8.47e-05	0.000908	CcSEcCtD
Bismuth Subsalicylate—Headache—Etoposide—lung cancer	8.42e-05	0.000903	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Paclitaxel—lung cancer	8.38e-05	0.000899	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Doxorubicin—lung cancer	8.37e-05	0.000897	CcSEcCtD
Bismuth Subsalicylate—Rash—Paclitaxel—lung cancer	8.31e-05	0.000891	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Paclitaxel—lung cancer	8.3e-05	0.000891	CcSEcCtD
Bismuth Subsalicylate—Headache—Paclitaxel—lung cancer	8.26e-05	0.000886	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Methotrexate—lung cancer	8.12e-05	0.000871	CcSEcCtD
Bismuth Subsalicylate—Infection—Methotrexate—lung cancer	8e-05	0.000858	CcSEcCtD
Bismuth Subsalicylate—Nausea—Etoposide—lung cancer	7.98e-05	0.000856	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Docetaxel—lung cancer	7.9e-05	0.000848	CcSEcCtD
Bismuth Subsalicylate—Nausea—Paclitaxel—lung cancer	7.83e-05	0.00084	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Methotrexate—lung cancer	7.68e-05	0.000823	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Docetaxel—lung cancer	7.64e-05	0.00082	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Docetaxel—lung cancer	7.39e-05	0.000792	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Methotrexate—lung cancer	7.16e-05	0.000768	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Docetaxel—lung cancer	7.1e-05	0.000762	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Methotrexate—lung cancer	7.09e-05	0.00076	CcSEcCtD
Bismuth Subsalicylate—Rash—Docetaxel—lung cancer	7.04e-05	0.000756	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Docetaxel—lung cancer	7.04e-05	0.000755	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Doxorubicin—lung cancer	7.03e-05	0.000754	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Methotrexate—lung cancer	7e-05	0.000751	CcSEcCtD
Bismuth Subsalicylate—Headache—Docetaxel—lung cancer	7e-05	0.000751	CcSEcCtD
Bismuth Subsalicylate—Oedema—Doxorubicin—lung cancer	6.97e-05	0.000748	CcSEcCtD
Bismuth Subsalicylate—Infection—Doxorubicin—lung cancer	6.93e-05	0.000743	CcSEcCtD
Bismuth Subsalicylate—Pain—Methotrexate—lung cancer	6.89e-05	0.000739	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Doxorubicin—lung cancer	6.65e-05	0.000713	CcSEcCtD
Bismuth Subsalicylate—Nausea—Docetaxel—lung cancer	6.64e-05	0.000712	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Methotrexate—lung cancer	6.64e-05	0.000712	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Methotrexate—lung cancer	6.4e-05	0.000686	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Methotrexate—lung cancer	6.37e-05	0.000683	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Doxorubicin—lung cancer	6.2e-05	0.000665	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Doxorubicin—lung cancer	6.14e-05	0.000658	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Doxorubicin—lung cancer	6.06e-05	0.00065	CcSEcCtD
Bismuth Subsalicylate—Constipation—Doxorubicin—lung cancer	5.96e-05	0.00064	CcSEcCtD
Bismuth Subsalicylate—Pain—Doxorubicin—lung cancer	5.96e-05	0.00064	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Doxorubicin—lung cancer	5.75e-05	0.000616	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Methotrexate—lung cancer	5.7e-05	0.000611	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Doxorubicin—lung cancer	5.54e-05	0.000594	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Doxorubicin—lung cancer	5.51e-05	0.000591	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Methotrexate—lung cancer	5.51e-05	0.000591	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Methotrexate—lung cancer	5.32e-05	0.000571	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Methotrexate—lung cancer	5.12e-05	0.000549	CcSEcCtD
Bismuth Subsalicylate—Rash—Methotrexate—lung cancer	5.08e-05	0.000545	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Methotrexate—lung cancer	5.07e-05	0.000544	CcSEcCtD
Bismuth Subsalicylate—Headache—Methotrexate—lung cancer	5.04e-05	0.000541	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Doxorubicin—lung cancer	4.93e-05	0.000529	CcSEcCtD
Bismuth Subsalicylate—Nausea—Methotrexate—lung cancer	4.78e-05	0.000513	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Doxorubicin—lung cancer	4.77e-05	0.000512	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Doxorubicin—lung cancer	4.61e-05	0.000495	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Doxorubicin—lung cancer	4.43e-05	0.000475	CcSEcCtD
Bismuth Subsalicylate—Rash—Doxorubicin—lung cancer	4.4e-05	0.000472	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Doxorubicin—lung cancer	4.39e-05	0.000471	CcSEcCtD
Bismuth Subsalicylate—Headache—Doxorubicin—lung cancer	4.37e-05	0.000468	CcSEcCtD
Bismuth Subsalicylate—Nausea—Doxorubicin—lung cancer	4.14e-05	0.000444	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	1.95e-05	0.000285	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—IL6—lung cancer	1.94e-05	0.000282	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—UGT1A1—lung cancer	1.91e-05	0.000279	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PXN—lung cancer	1.91e-05	0.000278	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CNDP2—lung cancer	1.91e-05	0.000278	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GSTM2—lung cancer	1.91e-05	0.000278	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	1.9e-05	0.000278	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—RRM1—lung cancer	1.9e-05	0.000277	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GSTA3—lung cancer	1.9e-05	0.000277	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—AKR1C1—lung cancer	1.87e-05	0.000272	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—MTMR3—lung cancer	1.85e-05	0.00027	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GNG11—lung cancer	1.84e-05	0.000269	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.83e-05	0.000268	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PGAM1—lung cancer	1.81e-05	0.000264	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	1.8e-05	0.000263	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—RAF1—lung cancer	1.8e-05	0.000262	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—B4GALT5—lung cancer	1.78e-05	0.00026	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—PIK3CB—lung cancer	1.76e-05	0.000256	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ALDOA—lung cancer	1.76e-05	0.000256	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	1.75e-05	0.000256	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—ITGB1—lung cancer	1.74e-05	0.000254	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GSTA4—lung cancer	1.74e-05	0.000253	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CYP2A7—lung cancer	1.72e-05	0.000251	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NPPA—lung cancer	1.72e-05	0.000251	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	1.71e-05	0.00025	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—NCOA3—lung cancer	1.7e-05	0.000249	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.7e-05	0.000248	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GSTA2—lung cancer	1.69e-05	0.000247	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—SDC4—lung cancer	1.69e-05	0.000246	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PPIA—lung cancer	1.68e-05	0.000245	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.67e-05	0.000244	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—ALDOA—lung cancer	1.66e-05	0.000243	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ADCY1—lung cancer	1.66e-05	0.000242	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ABCG2—lung cancer	1.66e-05	0.000242	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GSTA1—lung cancer	1.63e-05	0.000238	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ENO2—lung cancer	1.63e-05	0.000237	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—HPGDS—lung cancer	1.63e-05	0.000237	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	1.62e-05	0.000236	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PPP2R1B—lung cancer	1.62e-05	0.000236	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ABCC3—lung cancer	1.61e-05	0.000236	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—IL2—lung cancer	1.61e-05	0.000235	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.59e-05	0.000233	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GSTT1—lung cancer	1.58e-05	0.00023	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—ADCY1—lung cancer	1.57e-05	0.000229	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—AKR1C1—lung cancer	1.56e-05	0.000228	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GCLC—lung cancer	1.56e-05	0.000227	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CYP2A6—lung cancer	1.56e-05	0.000227	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.55e-05	0.000227	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—ENO2—lung cancer	1.54e-05	0.000225	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—RRM1—lung cancer	1.54e-05	0.000224	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GSTA3—lung cancer	1.54e-05	0.000224	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—SMARCA4—lung cancer	1.53e-05	0.000223	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PPP2R1B—lung cancer	1.53e-05	0.000223	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—UGT1A1—lung cancer	1.52e-05	0.000221	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	1.49e-05	0.000217	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ENO1—lung cancer	1.48e-05	0.000216	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.47e-05	0.000215	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—AVP—lung cancer	1.46e-05	0.000214	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GNG11—lung cancer	1.46e-05	0.000214	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.46e-05	0.000212	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.45e-05	0.000212	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—B4GALT5—lung cancer	1.44e-05	0.000211	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	1.44e-05	0.00021	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—ABCB1—lung cancer	1.42e-05	0.000207	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—SRC—lung cancer	1.41e-05	0.000205	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GSTA4—lung cancer	1.4e-05	0.000205	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—ENO1—lung cancer	1.4e-05	0.000204	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ALDOA—lung cancer	1.39e-05	0.000203	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.37e-05	0.0002	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—VEGFA—lung cancer	1.37e-05	0.0002	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GSTA2—lung cancer	1.37e-05	0.0002	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—NCOA3—lung cancer	1.35e-05	0.000197	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—MMP1—lung cancer	1.35e-05	0.000197	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.33e-05	0.000194	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CYP2E1—lung cancer	1.33e-05	0.000193	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GSTA1—lung cancer	1.32e-05	0.000193	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ADCY1—lung cancer	1.32e-05	0.000192	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ABCG2—lung cancer	1.32e-05	0.000192	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—NQO1—lung cancer	1.31e-05	0.000191	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ABCC3—lung cancer	1.31e-05	0.000191	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—APP—lung cancer	1.3e-05	0.00019	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—MAPK3—lung cancer	1.3e-05	0.000189	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—APOA1—lung cancer	1.29e-05	0.000189	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—FGF9—lung cancer	1.29e-05	0.000188	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ENO2—lung cancer	1.29e-05	0.000188	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—HPGDS—lung cancer	1.29e-05	0.000188	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.28e-05	0.000187	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PPP2R1B—lung cancer	1.28e-05	0.000187	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.27e-05	0.000186	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.27e-05	0.000185	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—AKR1C1—lung cancer	1.26e-05	0.000185	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GSTT1—lung cancer	1.25e-05	0.000183	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CYP2A6—lung cancer	1.24e-05	0.000181	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GCLC—lung cancer	1.24e-05	0.000181	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—JUNB—lung cancer	1.23e-05	0.00018	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.23e-05	0.00018	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—UGT1A1—lung cancer	1.23e-05	0.000179	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	1.21e-05	0.000177	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GNG11—lung cancer	1.18e-05	0.000173	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PIK3CG—lung cancer	1.18e-05	0.000172	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—STK11—lung cancer	1.18e-05	0.000172	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.18e-05	0.000172	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ENO1—lung cancer	1.17e-05	0.000171	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.17e-05	0.000171	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—EGF—lung cancer	1.17e-05	0.00017	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.15e-05	0.000168	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ALDOA—lung cancer	1.13e-05	0.000165	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—APOA1—lung cancer	1.12e-05	0.000163	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.11e-05	0.000162	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—CREBBP—lung cancer	1.1e-05	0.00016	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—NCOA3—lung cancer	1.09e-05	0.00016	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GSTP1—lung cancer	1.09e-05	0.000159	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—FOXO3—lung cancer	1.08e-05	0.000158	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.08e-05	0.000157	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—PIK3CA—lung cancer	1.07e-05	0.000156	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ADCY1—lung cancer	1.06e-05	0.000155	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ABCG2—lung cancer	1.06e-05	0.000155	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CAT—lung cancer	1.06e-05	0.000155	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.06e-05	0.000154	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CYP2E1—lung cancer	1.05e-05	0.000154	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—HPGDS—lung cancer	1.04e-05	0.000152	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ENO2—lung cancer	1.04e-05	0.000152	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—NQO1—lung cancer	1.04e-05	0.000152	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PIK3CD—lung cancer	1.04e-05	0.000152	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PPP2R1B—lung cancer	1.04e-05	0.000151	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ABCB1—lung cancer	1.03e-05	0.000151	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.02e-05	0.000149	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.02e-05	0.000149	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—TYMS—lung cancer	1.02e-05	0.000148	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GSTT1—lung cancer	1.01e-05	0.000148	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GSTM1—lung cancer	1e-05	0.000147	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GCLC—lung cancer	1e-05	0.000146	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CYP2A6—lung cancer	1e-05	0.000146	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	9.97e-06	0.000146	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—HES1—lung cancer	9.57e-06	0.00014	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CYP1A1—lung cancer	9.52e-06	0.000139	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ENO1—lung cancer	9.49e-06	0.000138	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—CREBBP—lung cancer	9.48e-06	0.000138	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	9.45e-06	0.000138	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ERCC2—lung cancer	9.44e-06	0.000138	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—STK11—lung cancer	9.38e-06	0.000137	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—RAF1—lung cancer	9.27e-06	0.000135	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PIK3CB—lung cancer	9.05e-06	0.000132	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—ERCC2—lung cancer	8.95e-06	0.000131	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	8.8e-06	0.000128	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—ERBB3—lung cancer	8.75e-06	0.000128	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—AKT1—lung cancer	8.74e-06	0.000128	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GSTP1—lung cancer	8.68e-06	0.000127	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CYP2E1—lung cancer	8.51e-06	0.000124	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CAT—lung cancer	8.44e-06	0.000123	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—NQO1—lung cancer	8.42e-06	0.000123	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—EP300—lung cancer	8.39e-06	0.000122	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—TERT—lung cancer	8.39e-06	0.000122	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—IL2—lung cancer	8.31e-06	0.000121	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	8.24e-06	0.00012	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ABCB1—lung cancer	8.21e-06	0.00012	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—APOA1—lung cancer	8.17e-06	0.000119	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	8.16e-06	0.000119	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—FGFR1—lung cancer	8.15e-06	0.000119	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—TYMS—lung cancer	8.07e-06	0.000118	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—RAF1—lung cancer	8.03e-06	0.000117	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—HIF1A—lung cancer	8.02e-06	0.000117	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GSTM1—lung cancer	7.97e-06	0.000116	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	7.82e-06	0.000114	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—APOA1—lung cancer	7.74e-06	0.000113	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—STK11—lung cancer	7.59e-06	0.000111	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CYP1A1—lung cancer	7.56e-06	0.00011	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ERCC2—lung cancer	7.5e-06	0.000109	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—EP300—lung cancer	7.46e-06	0.000109	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PIK3CG—lung cancer	7.46e-06	0.000109	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—SRC—lung cancer	7.25e-06	0.000106	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PTEN—lung cancer	7.12e-06	0.000104	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—POMC—lung cancer	7.1e-06	0.000104	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—APC—lung cancer	7.07e-06	0.000103	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—KIT—lung cancer	7.07e-06	0.000103	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—VEGFA—lung cancer	7.06e-06	0.000103	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GSTP1—lung cancer	7.02e-06	0.000102	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—EGF—lung cancer	6.99e-06	0.000102	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—NRAS—lung cancer	6.98e-06	0.000102	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CREBBP—lung cancer	6.91e-06	0.000101	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CAT—lung cancer	6.83e-06	9.97e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—EP300—lung cancer	6.79e-06	9.91e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—MAPK3—lung cancer	6.68e-06	9.75e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—BRAF—lung cancer	6.64e-06	9.7e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ABCB1—lung cancer	6.64e-06	9.7e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—IL6R—lung cancer	6.56e-06	9.58e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PIK3CD—lung cancer	6.56e-06	9.57e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CREBBP—lung cancer	6.55e-06	9.56e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—TYMS—lung cancer	6.53e-06	9.52e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—APOA1—lung cancer	6.48e-06	9.46e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ALB—lung cancer	6.47e-06	9.44e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GSTM1—lung cancer	6.45e-06	9.41e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—MAP2K1—lung cancer	6.26e-06	9.13e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PIK3CD—lung cancer	6.21e-06	9.07e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	6.21e-06	9.06e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CYP1A1—lung cancer	6.11e-06	8.92e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ERCC2—lung cancer	6.06e-06	8.85e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—KRAS—lung cancer	6.01e-06	8.76e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PIK3CG—lung cancer	5.92e-06	8.64e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PIK3CB—lung cancer	5.71e-06	8.34e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PTGS2—lung cancer	5.66e-06	8.26e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—POMC—lung cancer	5.63e-06	8.22e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—MDM2—lung cancer	5.57e-06	8.12e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—RAF1—lung cancer	5.55e-06	8.1e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PIK3CA—lung cancer	5.52e-06	8.05e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CREBBP—lung cancer	5.49e-06	8.01e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—ERBB2—lung cancer	5.49e-06	8.01e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PIK3CB—lung cancer	5.42e-06	7.9e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—MTOR—lung cancer	5.42e-06	7.9e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CD4—lung cancer	5.41e-06	7.89e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—TP53—lung cancer	5.34e-06	7.79e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—APOA1—lung cancer	5.25e-06	7.66e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PIK3CD—lung cancer	5.2e-06	7.59e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ALB—lung cancer	5.14e-06	7.5e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—HRAS—lung cancer	5.1e-06	7.45e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.02e-06	7.33e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PTEN—lung cancer	4.94e-06	7.21e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PIK3CG—lung cancer	4.79e-06	6.99e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—EP300—lung cancer	4.71e-06	6.87e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CDKN1A—lung cancer	4.69e-06	6.85e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PTEN—lung cancer	4.68e-06	6.83e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—POMC—lung cancer	4.56e-06	6.65e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PIK3CB—lung cancer	4.54e-06	6.62e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—AKT1—lung cancer	4.51e-06	6.58e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—EP300—lung cancer	4.46e-06	6.51e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CREBBP—lung cancer	4.44e-06	6.48e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—SRC—lung cancer	4.34e-06	6.33e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PIK3CD—lung cancer	4.21e-06	6.14e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—STAT3—lung cancer	4.19e-06	6.11e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NRAS—lung cancer	4.18e-06	6.09e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—MAPK3—lung cancer	4e-06	5.84e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PTEN—lung cancer	3.92e-06	5.72e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—MYC—lung cancer	3.89e-06	5.68e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—EGFR—lung cancer	3.8e-06	5.55e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—EP300—lung cancer	3.74e-06	5.45e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PIK3CB—lung cancer	3.67e-06	5.36e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PTGS2—lung cancer	3.64e-06	5.31e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—KRAS—lung cancer	3.59e-06	5.24e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PIK3CA—lung cancer	3.48e-06	5.08e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PIK3CA—lung cancer	3.3e-06	4.82e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PTEN—lung cancer	3.17e-06	4.63e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—HRAS—lung cancer	3.05e-06	4.46e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—EP300—lung cancer	3.02e-06	4.41e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—IL6—lung cancer	2.92e-06	4.27e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—AKT1—lung cancer	2.85e-06	4.15e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PIK3CA—lung cancer	2.77e-06	4.04e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—AKT1—lung cancer	2.7e-06	3.94e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—AKT1—lung cancer	2.26e-06	3.3e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PIK3CA—lung cancer	2.24e-06	3.26e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—AKT1—lung cancer	1.83e-06	2.67e-05	CbGpPWpGaD
